Cardiovascular Therapeutics

/ Table of Contents

Table of Contents

Table of Contents

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 3939360
- Research Article

KCa3.1 Promotes Proinflammatory Exosome Secretion by Activating AKT/Rab27a in Atrial Myocytes during Rapid Pacing

Dishiwen Liu | Huiyu Chen | ... | Qingyan Zhao

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 9915178
- Research Article

Mass Cytometry Reveals the Imbalanced Immune State in the Peripheral Blood of Patients with Essential Hypertension

Rui Yang | Yuhong He | ... | Bingyang Liu

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 2108584
- Research Article

Pharmacological Activation of Rev-erbα Attenuates Doxorubicin-Induced Cardiotoxicity by PGC-1α Signaling Pathway

Runmei Zou | Shuo Wang | ... | Cheng Wang

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 5693732
- Research Article

Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway

Anwu Huang | Zhaolin Wang | ... | Wenbing Jiang

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 8047752
- Research Article

DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1α Pathway and ERp57

Xiaojing Zhang | Ximin Wu | ... | Xin Deng

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 5996144
- Research Article

Identification of Potential Biomarkers for Coronary Artery Disease Based on Cuproptosis

Bohong Zhang | Mingliang He

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 2342111
- Research Article

Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial

Litao Zhang | Sha Li | ... | Yanli Long

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 5126825
- Research Article

The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients

Irmelin I. A. Biesenbach | Laurits J. Heinsen | ... | Kenneth Egstrup

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 4444708
- Research Article

Effect of TRIB1 Variant on Lipid Profile and Coronary Artery Disease: A Systematic Review and Meta-Analysis

Baozhu Wei | Yang Liu | ... | Zhi Luo

Cardiovascular Therapeutics -
Special Issue
Volume 2023
- Article ID 7362551
- Research Article

An Updated Meta-Analysis for Safety Evaluation of Alirocumab and Evolocumab as PCSK9 Inhibitors

Hye Duck Choi | Ji Hae Kim

Cardiovascular Therapeutics -
Special Issue
Volume 2022
- Article ID 8367444
- Research Article

Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials

Armin Attar | Arman Karimi Behnagh | ... | Ali Kabir

Cardiovascular Therapeutics -
Special Issue
Volume 2022
- Article ID 1407563
- Research Article

Predicting Risk Factors of Acute Kidney Injury in the First 7 Days after Admission: Analysis of a Group of Critically Ill Patients

Kexin Wen | Yongqing Huang | ... | Dengfeng Geng

Cardiovascular Therapeutics -
Special Issue
Volume 2022
- Article ID 4114817
- Research Article

The Effect of the Tongyang Huoxue Recipe (TYHX) on the I_to/I_Kur in Ischemia/Reperfusion Sinoatrial Node Cells

Yanli Wang | Qiaomin Wu | ... | Ruxiu Liu

Cardiovascular Therapeutics -
Special Issue
Volume 2022
- Article ID 1554875
- Review Article

Vericiguat: A New Hope for Heart Failure Patients

Raquel Chiles | Rami A. Al-Horani

Cardiovascular Therapeutics -
Special Issue
Volume 2022
- Article ID 1652315
- Research Article

Long Noncoding RNA SNHG4 Attenuates the Injury of Myocardial Infarction via Regulating miR-148b-3p/DUSP1 Axis

Sheng Wang | Zhaoyun Cheng | ... | Gaojun Xu

1|2|3|4|5|6|7|8

Evaluate your manuscript with the free Manuscript Language Checker

Author guidelines

Editorial board

Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.